Catecholamines and cardiovascular disorders: pathophysiologic considerations.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Heart Journal

• Publication date

  1989-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-8703(89)90610-8PMID 2679019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial catecholamines and their biosynthetic enzymes in various human heart diseases.

  2009cited by this paper
• Coexistence of catecholamine and methionine enkephalin-Arg6-Gly7-Leu8 in neurons of the rat ventrolateral medulla oblongata

  2004cited by this paper
• Catecholamine cardiotoxicity in pheochromocytoma.

  1989cited by this paper
• Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy.

  1989cited by this paper
• Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

  1989cited by this paper
• Measurement of adrenolutin as an oxidation product of catecholamines in plasma

  1989cited by this paper
• Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure.

  1987cited by this paper
• Involvement of Catecholamines in the Development of Diabetic Cardiomyopathy

  1987cited by this paper
• Norepinephrine storage, distribution, and release in diabetic cardiomyopathy.

  1987cited by this paper
• Altered Norepinephrine Turnover and Metabolism in Diabetic Cardiomyopathy

  1986cited by this paper
• Does norepinephrine play a central causative role in the process of cardiac hypertrophy?

  1985cited by this paper
• Catecholamine cardiotoxicity.

  1985cited by this paper
• Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.

  1984cited by this paper
• Norepinephrine turnover in the heart and blood vessels of rats subjected to bilateral renal infarction.

  1984cited by this paper
• Plasma catecholamines in clinical studies of cardiovascular diseases.

  1984cited by this paper
• Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.

  1984cited by this paper
• Plasma catecholamines in clinical studies of cardiovascular diseases.

  1984cited by this paper
• Medullary catecholamine inputs to the anteroventral third ventricular cardiovascular regulatory region in the rat.

  1983cited by this paper
• Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severity.

  1982cited by this paper
• Increased dopamine in the failing hamster heart: transvesicular transport of dopamine limits the rate of norepinephrine synthesis.

  1982cited by this paper
• Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

  1982cited by this paper
• Myocardial cell damage and cardiovascular changes due to i.v. infusion of adrenochrome in rats.

  1982cited by this paper
• The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat.

  1982cited by this paper
• Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias.

  1981cited by this paper
• Adrenochrome-induced coronary artery constriction in the rat heart.

  1981cited by this paper
• Norepinephrine Kinetics in Essential Hypertension

  1981cited by this paper
• Plasma Norepinephrine in Essential Hypertension: A Study of the Studies

  1981cited by this paper
• Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.

  1981cited by this paper
• Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy.

  1981cited by this paper
• Concentration of catecholamines in human cardiac muscle.

  1979cited by this paper
• Uptake of catecholamines by human cardiac muscle in vitro.

  1979cited by this paper
• Plasma norepinephrine in congestive heart failure.

  1978cited by this paper
• Studies of auricular catecholamines by fluorescence histochemistry in various heart diseases of man

  1977cited by this paper
• Norepinephrine Turnover in the Heart and Spleen of the Cardiomyopathic Syrian Hamster

  1975cited by this paper
• Plasma Norepinephrine and Epinephrine in Untreated Diabetics, During Fasting and After Insulin Administration

  1974cited by this paper
• Determinants of cardiac noradrenaline depletion in human congestive failure.

  1973cited by this paper
• Serial Determination of Plasma Catecholamines in Myocardial Infarction

  1972cited by this paper
• Cardiac catecholamine synthesis, turnover, and metabolism with isoproterenol-induced myocytolysis.

  1971cited by this paper
• Abnormal Storage of Norepinephrine in Experimental Hypertension in the Rat

  1967cited by this paper
• CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.

  1965cited by this paper
• MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE.

  1963cited by this paper
• Plasma Catechol Amine Concentrations in Myocardial Infarction and Angina Pectoris

  1959cited by this paper

• Oxidative Products of Catecholamines During Heightened Sympathetic Activity Due to Congestive Heart Failure: Possible Role of Antioxidants

  2024cites this paper
• Syndrome X: radionuclide studies of myocardial perfusion in patients with chest pain and normal coronary arteriograms

  2004cites this paper
• Beneficial Effect of Portacaval Shunt on Cardiac Contractility in Dogs

  2001cites this paper
• The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging.

  2000cites this paper
• Stress, sympathetic activity and heart disease: Is there any common mediator?

  1998cites this paper
• [Cardiomyopathy induced by catecholamines in neuroblastoma].

  1997cites this paper
• Myocardiopathie dilatée aux catécholamines dans le neuroblastome

  1997cites this paper
• Catecholamines: the first messengers

  1994cites this paper
• Antagonistic effects of epinephrine and helium-neon (He-Ne) laser irradiation on red blood cells deformability

  1994cites this paper
• Observations on atrial natriuretic peptide, sympathetic activity and renal Ca2+ pump in diabetic and hypertensive rats

  1993cites this paper
• Coronary heart disease in the absence of hypercholesterolaemia.

  1992cites this paper
• Response to editorial on antioxidant therapy for chronic heart failure.

  1992cites this paper
• Correspondence

  1992cites this paper
• Antioxidant therapy in congestive heart failure: is there any advantage?

  1991cites this paper
• Impaired Inotropic Responses to Adrenergic Stimulation Following Aortic Constriction: Role of Oxidation Product of Catecholamines

  1991cites this paper
• The Adrenochrome Hypothesis and Psychiatry

  1990cites this paper
• Coronary angioplasty for medically refractory unstable angina within 30 days of acute myocardial infarction.

  1990cites this paper